Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia

Leukocyte immunoglobulin (Ig)-like receptor Bs (LILRBs), a family of type I transmembrane glycoproteins, are known to inhibit immune activation. Here, we comprehensively evaluated the molecular, prognostic, and immunological characteristics of LILRB members in a broad spectrum of cancer types, focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zi-jun, Zhang, Xin-long, Jin, Ye, Wang, Shi-sen, Gu, Yu, Ma, Ji-chun, Wen, Xiang-mei, Leng, Jia-yan, Mao, Zhen-wei, Lin, Jiang, Qian, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233190/
https://www.ncbi.nlm.nih.gov/pubmed/35795094
http://dx.doi.org/10.1016/j.omto.2022.05.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233190/
https://www.ncbi.nlm.nih.gov/pubmed/35795094
http://dx.doi.org/10.1016/j.omto.2022.05.011

Ejemplares similares